Learn / AVTX
NASDAQ: AVTX
Avalo Therapeutics (AVTX) stock, explained like you're 5
Avalo Therapeutics trades on the Nasdaq under the ticker AVTX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 732 million dollars.
- Ticker
- AVTX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 732 million dollars
Is Avalo Therapeutics a small, medium or large cap company?
No. Avalo Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 732 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Avalo Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves AVTX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- (AVTX) Risk Channels and Responsive Allocation (Stock Traders Daily)
- H.C. Wainwright reiterates Avalo Therapeutics stock rating at buy (Investing.com)
- AVTX Oct 2026 20.000 put (AVTX261016P00020000) Interactive Stock Chart (Yahoo! Finance Canada)
- AVTX Forecast Price Target Prediction for 2027 (TradingView)
- Three new hires receive options to buy Avalo shares for $15.47 each (Stock Titan)
Follow AVTX in your daily brief
Each trading day at 5 PM ET we post what happened to Avalo Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow AVTX
Questions about Avalo Therapeutics stock
What does Avalo Therapeutics do?
Avalo Therapeutics trades on the Nasdaq under the ticker AVTX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 732 million dollars.
What is the ticker symbol for Avalo Therapeutics?
Avalo Therapeutics trades under the ticker AVTX on the Nasdaq.
What is Avalo Therapeutics's market cap?
Avalo Therapeutics is a small cap stock with a market cap of about 732 million dollars.
How does Avalo Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves AVTX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow AVTX stock every day?
Add AVTX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.